| Literature DB >> 29762478 |
Lucio Della Guardia1, Michael Alex Thomas2, Hellas Cena3.
Abstract
Recent epidemiological findings suggest that high levels of dietary acid load can affect insulin sensitivity and glucose metabolism. Consumption of high protein diets results in the over-production of metabolic acids which has been associated with the development of chronic metabolic disturbances. Mild metabolic acidosis has been shown to impair peripheral insulin action and several epidemiological findings suggest that metabolic acid load markers are associated with insulin resistance and impaired glycemic control through an interference intracellular insulin signaling pathways and translocation. In addition, higher incidence of diabetes, insulin resistance, or impaired glucose control have been found in subjects with elevated metabolic acid load markers. Hence, lowering dietary acid load may be relevant for improving glucose homeostasis and prevention of type 2 diabetes development on a long-term basis. However, limitations related to patient acid load estimation, nutritional determinants, and metabolic status considerably flaws available findings, and the lack of solid data on the background physiopathology contributes to the questionability of results. Furthermore, evidence from interventional studies is very limited and the trials carried out report no beneficial results following alkali supplementation. Available literature suggests that poor acid load control may contribute to impaired insulin sensitivity and glucose homeostasis, but it is not sufficiently supportive to fully elucidate the issue and additional well-designed studies are clearly needed.Entities:
Keywords: acid–base; diabetes; dietary acid load; glucose homeostasis; insulin resistance; metabolic acidosis; metabolism; western diet
Mesh:
Substances:
Year: 2018 PMID: 29762478 PMCID: PMC5986498 DOI: 10.3390/nu10050618
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Indirect estimation of NEAP, according to available equations [27]
| Author | Equation |
|---|---|
| Frassetto et al. | NEAP (mEq/day) = [0.91 × protein (g/day) − 0.57 × potassium (mEq/day)] + 21 |
| Remer et al. | NEAPest (mEq/day) = PRAL * + OAest |
| Sebastian et al. | NEAPest (mEq/day) = PRAL + OAest § |
* PRAL (mEq/day) = 0.49 × protein (g/day) + 0.037 × phosphorus (mg/day) − 0.021 × potassium (mg/day) − 0.026 × magnesium (mg/day) − 0.013 × calcium (mg/day) [27]. OAest (mEq/day) = body surface area × 41/1.73 [27]. § OAest (mEq/day) = 32.9 + 0.15 × [sodium (mg/day) + potassium (mg/day) + calcium (mg/day) + magnesium (mg/day) − chloride (mg/day) – phosphorus (mg/day)].
Human studies showing the impact of metabolic acid load status on muscle mass.
| Author | Subjects 1 | Age (year) | Study Type | Variables Measured | Results | Duration/Design |
|---|---|---|---|---|---|---|
| Welch et al., 2013 [ | 2689 women | 18–79 | Cross-sectional | Fat mass | Lower quartile of PRAL correlates with a less preserved fat-free mass | - |
| Chan, 2015 [ | 3122 men and women | >65 | Cohort Prospective | Axial muscle mass | Participants in the highest quartile of energy-adjusted estimated NEAP lost significantly more muscle mass than those in the lowest | 4 years |
| Frassetto et al., 1997 [ | 14 postmenopausal women | 51–77 | Intervention clinical trial | NAE | Alkali supplementation reduced NAE and nitrogen excretion | 18 days |
| Ceglia et al., 2009 [ | 19 men and women | 54–82 | Double-blind, randomized, placebo-controlled study | IGF-I | KHCO3 reduced the rise in urinary nitrogen excretion that accompanied an increase in protein intake | 90 mmol/day |
| Dawson-Hughes, 2010 [ | 71 men | >50 | Double-blind, placebo-controlled trial | NAE | KHCO3 reduced NAE and nitrogen excretion. In women, bicarbonate increased double leg press power at 70% one repetition maximum by 13% | 67.5 mmol/day of KHCO3 for 3 months |
1 All studies are performed on healthy subjects with no metabolic conditions. 2 KHCO3 or placebo with a 16-day phase-in and two successive 10-day diets at low (0.5 g/kg) or high (1.5 g/kg) protein in randomly assigned with a five-day washout period between diets.
Synopsis of the studies investigating the correlation of markers of acid load with insulin resistance and diabetes *.
| Author | Subjects 1 | Age (year) | Study Type | Variables Measured | Results | Duration/Design |
|---|---|---|---|---|---|---|
| Farwell et al., 2008 [ | 1496 women | >12 | Cross-sectional | HCO3− | Lower anion gap and bicarbonates correlate with increased insulin resistance | - |
| Mandel et al., 2012 [ | 630 (and 730 controls) | 30–55 | Prospective nested case-control | HCO3− | Lower bicarbonates correlate with increased diabetes T2 incidence | 10 years |
| Fagherazzi et al., 2014 [ | 66, 485 women | mean 53 | Cohort retrospective | PRAL | Highest PRAL-NEAP quartile shows higher incidence of diabetes T2 compared to lowest | 14 years |
| Kiefte-de Jong et al., 2016 [ | 67,433 women 3 | 30–55 | Cohort retrospective | PRAL | Highest PRAL-NEAP and A:P quartile shows higher incidence of diabetes T2 compared to lowest | 24 years |
| Akter, et al., 2016 [ | 1536 men | 19–69 | Cross-sectional | PRAL, NEAP | PRAL and NEAP associated with HOMA-IR 5 | - |
| Akter, et al., 2016 [ | 27,809 men | 45–75 | Cohort retrospective | PRAL, NEAP | Only PRAL associates with T2D incidence in men < 50 year-old | 10 years |
| Xu et al., 2014 [ | 911 men | 70–71 | Cohort Prospective | PRAL, NEAP | No association of PRAL-NEAP with insulin sensitivity, β-cell function or diabetes incidence | 18 years |
| Kozan et al., 2017 [ | 20 men | 24–44 | Placebo-controlled, crossover trial | C-peptide | No effect of NaHCO3 on postprandial insulin, plasma glucose, C-peptide and GLP-1 compared to placebo | 0-180 min |
| Harris et al., 2010 [ | 153 men and women 6 | >50 | Randomized, placebo-controlled trial | HOMA-IR | No effect of either NaHCO3 or KHCO3 on insulin, plasma glucose and HOMA-IR compared to placebo | 84 days |
* Plasma bicarbonate was included as a marker of metabolic acidosis; 1 Healthy subjects in all studies reported, with no metabolic conditions at baseline; 2 Participants were also considered diabetic if reporting elevated glucose concentration (fasting glucose ≥ 7.0 mmol/L or random glucose ≥ 11.1 mmol/L), treatment with diabetes drugs, and/or fasting glucose or HbA1c ≥ 7%. (53.0 mmol/moL); 3 Participants were all health professionals; 4 animal protein-to-potassium ratio; 5 In the stratified analyses, positive associations were confined to subjects with lower BMIs (<23 kg/m2) (P 0.03 and 0.01 for PRAL Pand NEAP, respectively); 6 Euglycemic–hyperinsulinemic clamp technique and the GTT to determine insulin sensitivity and β-cells function (through the calculation of IGI). Diabetes incidence was defined using fasting concentration of glucose (fasting plasma glucose ≥ 7.0 mmol/L) or the use of glucose-lowering medication; 7 All menopausal women.
Figure 1Synopsis of the possible underlying mechanism. Cortisol and other secondary mediators interfere with peripheral insulin activity via both impairing insulin receptor signal transduction and lowering the activation of intracellular insulin cascade [23,24]. The de-phosphorylation of the insulin receptor and key regulators, such as Akt [20,21], suppresses the translocation of GLUT4 in target tissues and downregulate the anabolic reactions propelled by insulin, including the inhibition of muscle protein breakdown [54,58,59]. This mechanism is likely to be independently promoted by pH imbalance secondary to acid load increase, and may account for the preservation of muscle mass when the acid load is low [63,64]. * Factors inducing the increase of acid load: catabolism end-products, metabolic conditions, kidney failure.